American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 18-23 , July 2009

Dietary Phosphorus Restriction in Dialysis Patients: Potential Impact of Processed Meat, Poultry, and Fish Products as Protein Sources

  • Richard A. Sherman, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Richard A. Sherman, MD, Department of Medicine, Division of Nephrology, UMDNJ–Robert Wood Johnson Medical School, One Robert Wood Johnson Pl, PO Box 19, New Brunswick, NJ 08903
    • ,
  • Ojas Mehta, DO

Received 21 October 2008 ,Accepted 12 January 2009.

References 

  1. Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;52:519–530
  2. Wald R, Sarnak MJ, Tighiouart H, et al. Disordered mineral metabolism in hemodialysis patients: An analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2008;52:431–540
  3. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  4. Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15:770–779
  5. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70:771–780
  6. Melamed ML, Eustace JA, Poantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int. 2006;70:351–357
  7. Kestenbaum B. Phosphate metabolism in the setting of chronic kidney disease: Significance and recommendations for treatment. Semin Dial. 2007;20:286–294
  8. Messa P, Gropuzzo M, Cleva G, et al. Behavior of phosphate removal with different dialysis schedules. Nephrol Dial Transplant. 1998;13(suppl B):S43–S48
  9. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Garbani E, Zehnder CE. Increasing blood flow increases Kt/V urea and potassium removal but fails to improve phosphate removal. Clin Nephrol. 2003;59:130–136
  10. Al-Hejaili F, Kortas C, Leitch R, et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol. 2003;14:2322–2328
  11. Kooienga L. Phosphorus balance with daily dialysis. Semin Dial. 2007;20:342–345
  12. Tomasello S, Dhupar S, Sherman RA. Phosphate binders, K/DOQI guidelines, and compliance: The unfortunate reality. Dial Transplant. 2004;33:236–240
  13. Uribarri J. The obsession with high dietary protein intake in ESRD patients on dialysis: Is it justified?. Nephron. 2000;86:105–108
  14. Kalantar-Zadeh K, Supayndh O, Lehn RS, McAllister CJ, Kopple JD. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr. 2003;13:15–25
  15. Sherman RA. Dietary phosphate restriction and protein intake in dialysis patients: A misdirected focus. Semin Dial. 2007;20:16–18
  16. Paduval RD, Wolgemuth C, Ferrell J, Hammes MS. Hyperphosphatemia in dialysis patients: Is there a role for focused counseling?. J Ren Nutr. 2003;13:219–223
  17. Pollock JB, Jaffery JB. Knowledge of phosphorus compared with other nutrients in maintenance dialysis patients. J Ren Nutr. 2007;17:323–328
  18. Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008;9:2
  19. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G. Food intake characteristics of hemodialysis patients obtained by food frequency questionnaire. J Ren Nutr. 2002;12:17–31
  20. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial. 2007;20:295–301
  21. Oenning LL, Vogel J, Calvo MS. Accuracy of methods estimating calcium and phosphorus intake in daily diets. J Am Diet Assoc. 1988;88:1076–1078
  22. Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: Implications for renal patients. J Ren Nutr. 2007;17:350–354
  23. Sarathy S, Sullivan C, Leon JB, Sehgal AR. Fast food, phosphorus-containing additives, and the renal diet. J Ren Nutr. 2008;18:466–470
  24. Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: Does it matter in nephrology?. Semin Dial. 2003;16:186–188
  25. Cupisti A, D'Alessandro C, Baldi R, Barsotti G. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia. J Ren Nutr. 2004;14:220–225
  26. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S202
  27. Murphy-Gutekunst L, Uribarri J. Hidden phosphorus-enhanced meats: Part 3. J Ren Nutr. 2005;15:E1–E4
  28. Schiller LR, Santa Ana CA, Sheikh MS, Emmett M, Fordtran JS. Effect of the time of administration of calcium acetate on phosphorus binding. N Engl J Med. 1989;320:1110–1113
  29. Burke SK, Slatopolsky EA, Goldberg DI. Renagel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers. Nephrol Dial Transplant. 1997;12:1640–1644
  30. Sprague SM, Abboud H, Qui P, Dauphin M, Zhang P, Finn WF. Lanthanum carbonate reduces phosphorus burden in patients with chronic kidney disease stages 3 and 4: Results from a phase 2, randomized, double-blind, placebo-controlled trial. Clin J Am Soc Nephrol. 2009;4:178–185
  31. Bell RR, Draper HH, Tzeng DYM, Shin HK, Schmidt GR. Physiological responses of human adults to foods containing phosphate additives. J Nutr. 1977;107:42–50
  32. Murphy-Gutekunst L. Hidden phosphorus in popular beverages. Nephrol Nurs J. 2005;32:443–445
  33. Ramirez JA, Emmett M, White MG, et al. The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int. 1986;30:753–759
  34. Ramdeen G, Tzamaloukas AH, Malhotra D, Leger A, Murata GH. Estimates of interdialytic sodium and water intake based on the balance principle: Differences between nondiabetic and diabetic subjects on hemodialysis. ASAIO J. 1998;44:812–817
  35. Shaldon S, Vienken J. The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients. Nephrol Dial Transplant. 2008;23:2118–2120
  36. Sehgal AR, Sullivan C, Leon JB, Bialostosky K. Public health approach to addressing hyperphosphatemia among dialysis patients. J Ren Nutr. 2008;18:256–261
  37. Karalis M. Food and Drug Administration petition on food labeling: An update from the American Diabetic Association and National Kidney Foundation. J Ren Nutr. 2007;17:423–424

 Originally published online as doi: 10.1053/j.ajkd.2009.01.269 on April 20, 2009.

PII: S0272-6386(09)00459-4

doi: 10.1053/j.ajkd.2009.01.269

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 18-23 , July 2009

Article Tools